HEALTHDAILY MAIL
'Holy Grail' blood test could prevent one in five cancer deaths - saving 30,000 lives, breakthrough trial suggests
A 'Holy Grail' blood test could prevent one in five cancer deaths, potentially saving 30,000 lives annually, according to a breakthrough trial. The test is described as a significant advancement in cancer prevention.
Related Signal
Adjacent reporting
- NHS trial of blood test offers 'genuine hope' for people with some cancers
- Does the PSA test for prostate cancer save lives? New data reverse gold-standard findings
- New blood test could identify heart and kidney disease years before people fall ill: Patients could benefit from life-changing early interventions
- Millions of breast cancer patients could be spared chemotherapy thanks to groundbreaking gene test
- Millions of breast cancer patients could safely avoid chemotherapy, study suggests
- Are cancer-screening blood tests close to prime time?